Michael Kranda - Director, Ptc Therapeutics, Inc
As of March 18, 2015
Michael Kranda Net Worth
- Net worth is estimated to be at least $314.49K
- Owns at least 2,242 units of Ptc Therapeutics, Inc stock
- Sold an estimated value of $218.83K in the last year at Ptc Therapeutics, Inc
Michael Kranda Trading
- Largest sale of shares was 2,500 units , worth over $182.04K on March 18, 2015
- In total has made about 4 transactions over a year
- Usually trades in March and January, with the busiest year in 2015 and 2014
Michael Kranda
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
Michael Kranda Mailing Address
- Mailing address is C/o Vulcan Ventures Incorporated 505 Fifth Avenue, Suite 900 Seattle WA 98104 WA
Ptc Therapeutics, Inc Insider Trading
- The most recent transaction was 897 units sold on April 21, 2022 by Matthew Klein worth over $38.14K
- In the last 9 years, insiders at Ptc Therapeutics, Inc sold an estimated value of $159.5M and bought an estimated value of $101.25M
- The most active traders are Walter Stuart Peltz, CHIEF EXECUTIVE OFFICER, Gregory Neil Almstead, Chief Technical Ops Officer, and Elliott Mark Boulding, EXEC. VP AND CLO
- Insider trading is most common in January, with the busiest year in 2020
PTC THERAPEUTICS, INC. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |